<DOC>
	<DOC>NCT02688699</DOC>
	<brief_summary>The investigators want to verify in a randomised trial, the effectiveness of EndoClotTM in preventing post-procedural bleeding after EMR (Endoscopic Mucosal Resection) or ESD (Endoscopic Submucosal Dissection) for sessile lesions &gt;20 mm in the right colon</brief_summary>
	<brief_title>Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract</brief_title>
	<detailed_description />
	<mesh_term>Colonic Polyps</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>&gt;18 years old lesions suitable for EMR or ESD &gt; 20 mm site in the right colon Severe cardiovascular pathologies Liver and Urinary dysfunctions Hematologic diseases Pregnancy and breast feeding impossible followup platelet and coagulation disorders (PLT &lt; 50 x 109/L, INR &gt; 2) Sensitivity or allergy to the drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>